01 23DARMERICA, LLC
02 3Qingdao Biopeptek Co., Ltd.
01 1ACTH 1-24 (Tetracosactide Acetate)
02 1Bremelanotide Acetate
03 1Buserelin Acetate
04 1CB4211 Acetate
05 1Elamipretide (SS-31) Acetate
06 1FGL Acetate
07 1FOX04-DRI
08 1FOXO4-DRI Acetate
09 1Gonadorelin Acetate
10 1Hexarelin Acetate
11 1Humanin Acetate
12 1KCF-18 Acetate
13 1KPV
14 1KPV Acetate
15 1Kisspeptin-10 Acetate
16 1Larazotide Acetate
17 1Long R3 IGF-1
18 1P21 Peptide Acetate
19 1PE 22-28 Acetate
20 1PTD-DBM
21 1PTD-DBM Acetate
22 1Pinealon Acetate
23 1Selank Acetate
24 1Setmelanotide (RM-493) Acetate
25 1Vasoactive Intestinal Peptide (VIP) Acetate
26 1iRGD Acetate
01 26U.S.A
NDC Package Code : 71052-517
Start Marketing Date : 2019-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-359
Start Marketing Date : 2019-11-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-546
Start Marketing Date : 2019-09-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-364
Start Marketing Date : 2019-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10mg/10mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-358
Start Marketing Date : 2019-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-093
Start Marketing Date : 2019-11-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5g/.5g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 71052-072
Start Marketing Date : 2024-09-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-180
Start Marketing Date : 2020-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-073
Start Marketing Date : 2019-08-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-013
Start Marketing Date : 2023-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A CEND-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CEND-1, including repackagers and relabelers. The FDA regulates CEND-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CEND-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CEND-1 supplier is an individual or a company that provides CEND-1 active pharmaceutical ingredient (API) or CEND-1 finished formulations upon request. The CEND-1 suppliers may include CEND-1 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CEND-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CEND-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CEND-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CEND-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CEND-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CEND-1 suppliers with NDC on PharmaCompass.
We have 2 companies offering CEND-1
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
